2007
DOI: 10.1111/j.1752-699x.2007.00024.x
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?

Abstract: We found this method successful in treating lobar atelectasis, which was resistant to conventional therapy with antibiotics and physiotherapy. In all but one of the cases we described, administration of DNase in this manner resulted in a radiographic and clinical improvement of the atelectasis. We recommend that respiratory physicians consider this as a second line treatment in the management of atelectasis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
2

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 12 publications
1
16
2
Order By: Relevance
“…Very few patients do not respond to the above measures, especially those with bronchiectasis or structural airway abnormalities like bronchomalacia. The use of flexible bronchoscopy as a 'secondary' treatment along with installation of DNase is described in patients not responding to usual treatment in small case series, 2,3 but no literature is available on the use of early therapeutic bronchoscopy in cystic fibrosis. The cause for recurrent lobar atelectasis in our patient is yet to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Very few patients do not respond to the above measures, especially those with bronchiectasis or structural airway abnormalities like bronchomalacia. The use of flexible bronchoscopy as a 'secondary' treatment along with installation of DNase is described in patients not responding to usual treatment in small case series, 2,3 but no literature is available on the use of early therapeutic bronchoscopy in cystic fibrosis. The cause for recurrent lobar atelectasis in our patient is yet to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…One hypothesis is that a massive influx of inflammatory mediators and cells (primarily DNA-rich neutrophils) results in direct injury to the airway, leading to production of secretions and airway obstruction with mucus and products of inflammatory cell breakdown including DNA [1]. Some existing therapies such as anti-inflammatory agents or DNAse might be rational in this setting [2]. These agents are often used in clinical practice but there are few data specifically supporting a pathophysiologic rationale for their use [24].…”
Section: Introductionmentioning
confidence: 99%
“…Some existing therapies such as anti-inflammatory agents or DNAse might be rational in this setting [2]. These agents are often used in clinical practice but there are few data specifically supporting a pathophysiologic rationale for their use [24]. …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Sometimes biopsy forceps or foreign body basket may have to be used to remove extremely tenacious mucous plugs. Bronchoscopic instillation of recombinant human DNase through bronchoscope was successful in improving atelectasis due to thick tenacious airway secretions unresponsive to medical treatment in selected cases of cystic fibrosis [9].…”
mentioning
confidence: 99%